Intercept Pharmaceuticals (ICPT)
$28.76 0.16 (0.55%)
16:54 EDT ICPT Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 850.81M
PE Ratio -2.06
Volume (Avg. Vol.) 552,600
Day's Range 27.76 - 29.07
52-Week Range 27.76 - 125.00
Dividend & Yield N/A (N/A)
ICPT Stock Predictions, Articles, and Intercept Pharmaceuticals News
- From InvestorPlace
- From the Web
As markets continue to hit all-time highs, consider taking profits in these stocks to sell before their companies report slowing growth.
Eli Lilly, Alexion and AbbVie are just some of the top healthcare stocks to buy here, now that disappointing news has driven them to cheap prices.
The economy may be slowing but these small-cap stocks have plenty of momentum. Keep these 7 names on your radar.
Canopy Growth, CVS Health, Intercept Pharmaceuticals, Rite Aid and UnitedHealth are our top stock trades to watch for Friday.
Apple, Facebook, Gold, Weight Watchers and Intercept Pharmaceuticals are setting up to be our top stock trades for Wednesday.
Intercept Pharmaceuticals news concerning the results from a recent Phase 3 clinical trial have ICPT stock heading higher today.
With the worst of the market turbulence hopefully in the rear-view mirror, these look like the best stocks to buy as the year winds down.
These 20 stocks are facing heavy pressure from short sellers - which could lead to epic gains if those traders are proven wrong.
After the market's rout, biotech stocks offer a huge value right now. Here are 5 that offer the best opportunities for investors.
Looking for blockbuster potential? These five biotech stocks may have found it in treating NASH -- an untapped market of up to $35 billion.
Intercept Pharmaceuticals (ICPT) stock took a hit on Tuesday following the release of a drug warning concerning its Ocaliva.
The following stocks were moving the Manufacturing sector today.
Biogen (BIIB), Intercept (ICPT) and Gilead Sciences (GILD) are all thought to be among biotech's best-looking stocks right now. Two out of three ain't bad.
The following stocks were the biggest movers and shakers in the Manufacturing sector today.
This week, the ratings of 19 Biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Navellier RatingsPowered by Portfolio Grader